Lee Sung bought CYTK

June 24, 2026 · Form 4 insider transaction

Lee Sung bought 23,370 shares of Cytokinetics, Incorporated at $48.51 per share, a transaction worth $1.13M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
23,370
Price
$48.51
Total value
$1.13M
InsiderLee Sung
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 24, 2026
Filing dateJune 29, 2026
Shares owned after86,591
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR